Entity Common Stock, Shares Outstanding of SAB Biotherapeutics, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
SAB Biotherapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2021 to Q3 2025.
  • SAB Biotherapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 10, 2025 was 47.6M shares, a 416% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)

SAB Biotherapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 47.6M +38.4M +416% Nov 10, 2025 10-Q 2025-11-14
Q2 2025 10.4M +1.18M +12.8% Aug 1, 2025 10-Q 2025-08-07
Q1 2025 9.29M +63.4K +0.69% Mar 21, 2025 10-K 2025-03-31
Q3 2024 9.23M -43.1M -82.4% Nov 1, 2024 10-Q 2024-11-06
Q2 2024 9.23M -43.1M -82.4% Aug 2, 2024 10-Q 2024-08-08
Q1 2024 9.23M -41.2M -81.7% Mar 18, 2024 10-K 2024-03-29
Q3 2023 52.3M +9.29M +21.6% Oct 31, 2023 10-Q 2023-11-13
Q2 2023 52.3M +9.29M +21.6% Jul 31, 2023 10-Q 2023-08-21
Q1 2023 50.4M +7.44M +17.3% Mar 28, 2023 10-K/A 2023-04-28
Q3 2022 43M Nov 3, 2022 10-Q 2022-11-14
Q2 2022 43M +28.2M +191% Jul 29, 2022 10-Q 2022-08-10
Q1 2022 43M +28.2M +190% Mar 28, 2022 10-K 2022-03-29
Q4 2021 43.5M Nov 15, 2021 10-Q 2021-11-22
Q2 2021 14.8M Aug 9, 2021 10-Q 2021-08-09
Q1 2021 14.8M Mar 29, 2021 10-K 2021-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.